- Home
- UNCY vs CLIR Comparison
UNCY vs CLIR Comparison
Compare UNCY & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- CLIR
- Stock Information
- Founded
- UNCY 2016
- CLIR 2008
- Country
- UNCY United States
- CLIR United States
- Employees
- UNCY N/A
- CLIR N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- UNCY Health Care
- CLIR Industrials
- Exchange
- UNCY Nasdaq
- CLIR Nasdaq
- Market Cap
- UNCY 71.8M
- CLIR 59.3M
- IPO Year
- UNCY 2021
- CLIR 2012
- Fundamental
- Price
- UNCY $0.60
- CLIR $0.58
- Analyst Decision
- UNCY Strong Buy
- CLIR Strong Buy
- Analyst Count
- UNCY 2
- CLIR 1
- Target Price
- UNCY $5.25
- CLIR $2.00
- AVG Volume (30 Days)
- UNCY 1.2M
- CLIR 94.7K
- Earning Date
- UNCY 05-12-2025
- CLIR 05-15-2025
- Dividend Yield
- UNCY N/A
- CLIR N/A
- EPS Growth
- UNCY N/A
- CLIR N/A
- EPS
- UNCY N/A
- CLIR N/A
- Revenue
- UNCY N/A
- CLIR $3,596,000.00
- Revenue This Year
- UNCY N/A
- CLIR $511.29
- Revenue Next Year
- UNCY $1,677.16
- CLIR $117.08
- P/E Ratio
- UNCY N/A
- CLIR N/A
- Revenue Growth
- UNCY N/A
- CLIR 49.65
- 52 Week Low
- UNCY $0.20
- CLIR $0.46
- 52 Week High
- UNCY $1.29
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- UNCY 54.18
- CLIR 40.05
- Support Level
- UNCY $0.45
- CLIR $0.54
- Resistance Level
- UNCY $0.63
- CLIR $0.62
- Average True Range (ATR)
- UNCY 0.06
- CLIR 0.07
- MACD
- UNCY 0.01
- CLIR 0.00
- Stochastic Oscillator
- UNCY 78.95
- CLIR 37.50
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.